Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 5 . 4

Several polygons, juxtaposed, joined or intersectingPlusieurs polygones, juxtaposés, accolés ou se coupant

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 12

Letters or numerals representing a heavenly body or a natural phenomenonLettres ou chiffres représentant un corps céleste ou un phénomène naturel

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Trademark usage description

medicated pharmaceutical and veterinary preparations, both prescription and over-the-counter, in the nature of for the treatment of central nervous sy Read More

Classification Information

Class [005]
Medicated pharmaceutical and veterinary preparations, both prescription and over-the-counter, in the nature of for the treatment of central nervous system disorders, in the nature of, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurologic illnesses, in the nature of, brain injury, spinal cord injury, seizure disorders, and psychiatric illnesses, in the nature of anxiety disorder, depression, Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Schizophrenia, Eating Disorders, Disruptive behaviour and dissocial disorders, Neurodevelopmental disorders; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, in the nature of post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, in the nature of post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases, in the nature of Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, in the nature of glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, in the nature of opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain, in the nature of failed back surgery syndrome, radiculopathy, in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, in the nature of headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases, in the nature of breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, in the nature of precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders, in the nature of treatment resistant depression, Post Traumatic Stress Disorder (PTSD), in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder, in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, in the nature of schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, shared psychotic disorder, substance-induced psychotic disorder, and paraphrenia, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders, in the nature of spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, in the nature of monotherapy and adjunctive use.

Classification kind code

Class [042]
Pharmaceutical research and development in the fields of headache, facial pain, impulse control disorders, neurological disorders, and neurodegenerative disorders, and consultation provided in conjunction therewith.

Classification kind code

Mark Details

Serial Number

2173153

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 29^th Nov 2022	Search Recorded
Submitted for opposition 20 on 29^th Nov 2022	Examiner's First Report
Submitted for opposition 223 on 29^th Nov 2022	Total Provisional Refusal
Submitted for opposition 67 on 07^th Oct 2022	Agent Name Changed
Submitted for opposition 48 on 04^th Aug 2022	Agent Changed
Submitted for opposition 257 on 17^th Mar 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 16^th Mar 2022	Created
Submitted for opposition 31 on 16^th Mar 2022	Formalized
Submitted for opposition 228 on 14^th Dec 2021	International Registration
Submitted for opposition 30 on 14^th Dec 2021	Filed

BIOHAVEN PHARMACEUTICALS

Classification Information

Classification kind code

Class [042]Pharmaceutical research and development in the fields of headache, facial pain, impulse control disorders, neurological disorders, and neurodegenerative disorders, and consultation provided in conjunction therewith.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Pharmaceutical research and development in the fields of headache, facial pain, impulse control disorders, neurological disorders, and neurodegenerative disorders, and consultation provided in conjunction therewith.